Full text
Earnings transcript
Read the complete earnings call transcript.
CGNT
Cognyte Software Ltd.
$8.41
-0.21
(-2.44%)
| Exchange: | NASDAQ |
| Market Cap: | 619.867M |
| Shares Outstanding: | 1.116M |
Delayed data
About The Company
| Sector: | TechnologyView sector performance | |||||
| Industry: | Software – InfrastructureView industry performance | |||||
| CEO: | Elad Sharon | |||||
| Full Time Employees: | 1710 | |||||
| Address: |
| |||||
| Website: | https://www.cognyte.com |
Cognyte Software Ltd., established in Herzliya, Israel, in 2020, delivers sophisticated investigative analytics software to a global array of governmental organizations and commercial businesses. Its flagship offering, branded “Actionable Intelligence for a Safer World,” is an open-source platform specifically engineered to expedite and bolster the efficacy of investigations. The company’s diverse portfolio of solutions includes advanced analytics for network intelligence, open source and threat intelligence, and operational intelligence. These versatile tools are crafted to address a wide variety of scenarios and serve an extensive user base, from data analysts and investigation managers to security operations center operators and field teams. Furthermore, Cognyte offers crucial supplementary services such as customer support, professional guidance, and integration assistance. Its clientele spans national, regional, and local government bodies, alongside commercial entities and physical security firms.
Click to read more…
Revenue Segmentation
CGNT full analysis
Welcome to MARKETSNAP’s SWOT analysis for Cognyte Software Ltd., also known by its ticker CGNT. If you’re a long-term investor looking to build wealth through smart stock picks, you’re in the right place. Today, we’re diving deep into Cognyte, a company that might not be on everyone’s radar but certainly deserves a closer look. Let’s unpack what makes this company tick, analyze its recent performance, and break down the strengths, weaknesses, opportunities, and threats that could shape its future. Stick…
Industry Peers
| TICKER | COMPANY | MKT CAP | P/E | FWD P/E | ROIC |
|---|---|---|---|---|---|
| CGNT | Cognyte Software Ltd. | 619.9M | — | 36.6 | 2.3% |
 YEXT | Yext, Inc. | 615.5M | 27.3 | 11.6 | 13.0% |
 KDK | Kodiak AI, Inc. Common Stock | 633.5M | — | — | -83.0% |
 CCSI | Consensus Cloud Solutions, Inc. | 642.6M | 7.3 | 5.9 | 17.6% |
 OSPN | OneSpan Inc. | 649.1M | 9.3 | 14.1 | 15.8% |
 HQ | Horizon Quantum Holdings Ltd. Class A … | 730.8M | — | 3.3 | -12.6% |
EPS
Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.
Earnings Call
AI summary
Key takeaways
Short, structured highlights from the call so you can focus on what matters.
Log in to continue
Log in to read the full transcript and AI-generated earnings summaries.
Login — it's freeIncome Statement
| Year | 2024 | 2025 | 2026 |
|---|---|---|---|
| Revenue | 313,404 | 350,632 | 400,041 |
| Gross Profit | 215,404 | 246,922 | 289,701 |
| EBITDA | 573 | 9,382 | 23,513 |
| Operating Income | -18,054 | -5,126 | 13,261 |
| Net Income | -15,570 | -12,051 | -638 |
(* All numbers are in thousands)
Balance Sheet
| Year | 2024 | 2025 | 2026 |
|---|---|---|---|
| Total Assets | 472,082 | 497,820 | 521,066 |
| Total Liabilities | 257,349 | 280,717 | 292,203 |
| Total Stockholders Equity | 197,875 | 198,192 | 206,544 |
| Total Debt | 33,363 | 35,530 | 36,542 |
| Cash and Cash Equivalents | 74,477 | 112,719 | 116,878 |
(* All numbers are in thousands)
Cash Flow Statement
| Year | 2024 | 2025 | 2026 |
|---|---|---|---|
| Operating Cash Flow | 34,561 | 46,782 | 40,331 |
| Capital Expenditure | -9,069 | -13,188 | -10,396 |
| Free Cash Flow | 25,492 | 33,594 | 29,935 |
| Net Income | -15,570 | -7,234 | -638 |
| Net Change in Cash | 41,352 | 32,508 | 3,778 |
(* All numbers are in thousands)
Analyst Estimates
| Fiscal Year | 2029 | Research Access | Research Access | Research Access | Research Access |
|---|---|---|---|---|---|
| Estimated Revenue (Low) | 447,319.426 | Research Access | Research Access | Research Access | Research Access |
| Estimated Revenue (High) | 456,291.770 | Research Access | Research Access | Research Access | Research Access |
| Estimated Revenue (Avg) | 453,300 | Research Access | Research Access | Research Access | Research Access |
| Estimated Ebitda (Low) | Research Access | Research Access | Research Access | Research Access | |
| Estimated Ebitda (High) | Research Access | Research Access | Research Access | Research Access | |
| Estimated Ebitda (Avg) | Research Access | Research Access | Research Access | Research Access | |
| Estimated Net Income (Low) | 0 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (High) | 0 | Research Access | Research Access | Research Access | Research Access |
| Estimated Net Income (Avg) | 0 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (Low) | 186,213.342 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (High) | 189,948.414 | Research Access | Research Access | Research Access | Research Access |
| Estimated SGA Expense (Avg) | 188,702.978 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (Avg) | 0 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (High) | 0 | Research Access | Research Access | Research Access | Research Access |
| Estimated EPS (Low) | 0 | Research Access | Research Access | Research Access | Research Access |
| Number of Analysts (Estimated Revenue) | 1 | Research Access | Research Access | Research Access | Research Access |
| Number of Analysts (Estimated EPS) | 0 | Research Access | Research Access | Research Access | Research Access |
Log in to continue
Log in and subscribe to Full Access to see up to 5 years of analyst estimates.
Login — it's free(* All numbers are in thousands)
Current Key Metrics
Log in to continue
Log in to see all key valuation metrics and ratios for this symbol.
Login — it's freeForward P/E Ratios
Log in to continue
Log in with Full Access for forward P/E high/low estimates and the full multi-year table.
Login — it's freeSWOT Analysis
Strengths (preview)
- Robust Revenue Growth: Cognyte reported a 16% year-over-year revenue increase in Q2 FY 2026, as highlighted in the earnings call transcript, reflecting strong demand for its solutions and effective execution of growth strategies.
- Positive Financial Performance: Key metrics from the income statement show consistent revenue and gross profit growth, supported by positive operating income and net income trends, indicating operational efficiency.
- Strong Cash Flow Generation: Cash flow statements reveal healthy net cash provided by operating activities and positive free cash flow, providing financial flexibility for reinvestment or debt management.
Log in with Research Access for Weaknesses, Opportunities, Threats, and the complete SWOT.
At what price to buy it? -
Intrinsic Value Calculator
Based on current fundamentals and analyst forecasts, MARKETSnap estimates CGNT intrinsic value between $5.07 – $5.35 per share. This depends on revenue growth, margins, and discount rate.
This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.
[intrinsic_calculator]
Common questions about CGNT valuation
Is Cognyte Software Ltd. (CGNT) overvalued or undervalued right now?
MARKETSnap estimates intrinsic value for Cognyte Software Ltd. (CGNT) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.
Is CGNT a buy, hold, or sell for long-term investors?
MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether CGNT trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.
What is CGNT’s P/E ratio?
You can see CGNT’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.
How is intrinsic value calculated for CGNT?
MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.
Is CGNT a good long-term investment?
Whether CGNT fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.
CGNT
1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.
Daily snapshot
-2.44
Trading Metrics:
| Open: | 8.6 | Previous Close: | 8.62 | |
| Day Low: | 8.39 | Day High: | 8.72 | |
| Year Low: | 6.29 | Year High: | 12.31 | |
| Price Avg 50: | 8.75 | Price Avg 200: | 8.89 | |
| Volume: | 918255 | Average Volume: | 688848 |
Log in to continue
Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.
Login — it's free
